enVVeno Medical Corp (NVNO)

SEC fundamentals · as filed in 10-Q FY2026, period ended Sep 30, 2026 · updated Oct 30, 2026

Verified against EDGAR
Total Assets
$19.5M
Stockholders' Equity
$16.9M
Cash & Equivalents
$2.6M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Sep 30, 2026, enVVeno Medical Corp reported net income of -$4.4M and total assets of $19.5M. Every figure below is taken directly from enVVeno Medical Corp's SEC filings: each links to the source document on EDGAR.

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025—-$19.5M
FY2024—-$21.8M
FY2023—-$23.5M
FY2022—-$24.7M
FY2021—-$16.5M
FY2020—-$9.1M
FY2019$31,243-$7.6M
FY2018$186,552-$13.0M
FY2017$422,111-$7.8M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
10-QJul 30, 2026on EDGAR ↗
8-KJul 14, 2026on EDGAR ↗
10-QMay 6, 2026on EDGAR ↗
8-KApr 29, 2026on EDGAR ↗
10-KMar 26, 2026on EDGAR ↗
8-KFeb 4, 2026on EDGAR ↗
8-KJan 20, 2026on EDGAR ↗
8-KDec 12, 2025on EDGAR ↗
8-KNov 20, 2025on EDGAR ↗
8-KNov 14, 2025on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Sep 30, 2026 · 10-Q

Total Assets$19.5Msource ↗
Stockholders’ Equity$16.9Msource ↗
Cash & Equivalents$2.6Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Sep 30, 2026

Revenue—source ↗
Net Income-$4.4Msource ↗
Operating Income-$4.5Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$2.9Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Sep 30, 2026

EPS (diluted)$-6.29source ↗
EPS (basic)$-6.29source ↗
Shares Outstanding694,826source ↗
Cash from Operations-$3.2Msource ↗
Cash from Financing$187,000source ↗
Cash from Investing$2.7Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
2
Net shares
-151

Restatement history

Point-in-time

1 of 202 annual fact-keys were materially restated between filings: what enVVeno Medical Corp first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches NVNO’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/NVNO

MCP tool: get_sec_fundamentals ticker=NVNO

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/NVNO/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=NVNO as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/NVNO/history

MCP tool: get_fundamentals_history ticker=NVNO

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/NVNO

MCP tool: get_financial_health ticker=NVNO

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.